These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Acyclovir kinetics after intravenous infusion. de Miranda P, Whitley RJ, Blum MR, Keeney RE, Barton N, Cocchetto DM, Good S, Hemstreet GP, Kirk LE, Page DA, Elion GB. Clin Pharmacol Ther; 1979 Dec; 26(6):718-28. PubMed ID: 227639 [Abstract] [Full Text] [Related]
5. Species differences in the disposition of acyclovir. de Miranda P, Krasny HC, Page DA, Elion GB. Am J Med; 1982 Jul 20; 73(1A):31-5. PubMed ID: 7102710 [Abstract] [Full Text] [Related]
6. The disposition of acyclovir in different species. de Miranda P, Krasny HC, Page DA, Elion GB. J Pharmacol Exp Ther; 1981 Nov 20; 219(2):309-15. PubMed ID: 7288622 [Abstract] [Full Text] [Related]
8. Overview of acyclovir pharmacokinetic disposition in adults and children. Blum MR, Liao SH, de Miranda P. Am J Med; 1982 Jul 20; 73(1A):186-92. PubMed ID: 7048911 [Abstract] [Full Text] [Related]
9. Pharmacokinetics and tolerance of acyclovir, a new anti-herpesvirus agent, in humans. Laskin OL, Longstreth JA, Saral R, de Miranda P, Keeney R, Lietman PS. Antimicrob Agents Chemother; 1982 Mar 20; 21(3):393-8. PubMed ID: 7103443 [Abstract] [Full Text] [Related]
11. Acyclovir clinical pharmacology. An overview. Lietman PS. Am J Med; 1982 Jul 20; 73(1A):193-6. PubMed ID: 7048912 [Abstract] [Full Text] [Related]
12. Determination of acyclovir and its metabolite 9-carboxymethoxymethylguanine in serum and urine using solid-phase extraction and high-performance liquid chromatography. Svensson JO, Barkholt L, Säwe J. J Chromatogr B Biomed Sci Appl; 1997 Mar 07; 690(1-2):363-6. PubMed ID: 9106067 [Abstract] [Full Text] [Related]
13. Pharmacokinetics and bioavailability of acyclovir in the dog. Krasny HC, de Miranda P, Blum MR, Elion GB. J Pharmacol Exp Ther; 1981 Feb 07; 216(2):281-8. PubMed ID: 7463350 [Abstract] [Full Text] [Related]
14. Pharmacokinetics of acyclovir in humans following intravenous administration. A model for the development of parenteral antivirals. Whitley RJ, Blum MR, Barton N, de Miranda P. Am J Med; 1982 Jul 20; 73(1A):165-71. PubMed ID: 7102700 [Abstract] [Full Text] [Related]
15. Simple high-performance liquid chromatographic method for the analysis of 9-(2-hydroxyethoxymethyl)guanine (acyclovir) in human plasma and urine. Land G, Bye A. J Chromatogr; 1981 Jun 12; 224(1):51-8. PubMed ID: 7263820 [Abstract] [Full Text] [Related]
16. Effect of renal failure on the pharmacokinetics of acyclovir. Laskin OL, Longstreth JA, Whelton A, Krasny HC, Keeney RE, Rocco L, Lietman PS. Am J Med; 1982 Jul 20; 73(1A):197-201. PubMed ID: 7102702 [No Abstract] [Full Text] [Related]
17. Effects of probenecid on the pharmacokinetics and elimination of acyclovir in humans. Laskin OL, de Miranda P, King DH, Page DA, Longstreth JA, Rocco L, Lietman PS. Antimicrob Agents Chemother; 1982 May 20; 21(5):804-7. PubMed ID: 7103460 [Abstract] [Full Text] [Related]